Role of noncoding RNA and protein interaction in pancreatic cancer

Zhang Li1, Tingting Zhang, Xiaojuan Yang

  • 1Center for Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

PubMed

Insights

Noncoding RNAs (ncRNAs) are crucial in pancreatic cancer development. Understanding ncRNA-protein interactions offers new avenues for pancreatic cancer research and treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Noncoding RNAs (ncRNAs) lack protein-coding potential but are increasingly recognized for their roles in disease.
  • Dysregulation of ncRNAs is common in pancreatic cancer, contributing to its pathogenesis.
  • Aberrant ncRNA expression stems from genetic and epigenetic alterations.

Purpose of the Study:

  • To review mechanisms of ncRNA dysregulation in pancreatic cancer.
  • To highlight the significance of ncRNA-protein interactions in pancreatic cancer progression.
  • To discuss the clinical relevance of ncRNAs in pancreatic cancer.

Main Methods:

  • Literature review of ncRNA function and dysregulation in pancreatic cancer.
  • Analysis of ncRNA roles as scaffolds or decoys modulating protein interactions.
  • Synthesis of current understanding of ncRNA-protein interactions in pancreatic cancer.

Main Results:

  • ncRNAs regulate gene expression by influencing protein interactions.
  • Dysregulated ncRNAs contribute to the progression of pancreatic cancer.
  • ncRNA-protein interactions are key to understanding pancreatic cancer biology.

Conclusions:

  • ncRNA dysregulation is a significant factor in pancreatic cancer pathogenesis.
  • ncRNA-protein interactions are critical for regulating cellular processes in pancreatic cancer.
  • Further research into ncRNA-protein interactions is vital for advancing pancreatic cancer translational research.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K